Skip to main content
Premium Trial:

Request an Annual Quote

NHLBI to Fund Application of 'Omics Data to Lung Diseases

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute seeks to fund new research projects that use and apply a wide range of 'omics data to the study of the genetic interactions involved in pulmonary disease.

In a new funding announcement, NHLBI said that molecular and genomic data has the potential to illuminate interactions between genes and gene products involved in lung diseases and could be used to develop new ways of treating them.

To tap into that potential, NHLBI plans to fund four-year projects to study this genetic interactivity by conducting integrative analysis of data from genomic, transcriptomic, proteomic, metabolomic, and phenotypic studies of pulmonary diseases, including data that highlights the differences between normal and diseased states and is derived from human cells.

The researchers also may propose a second phase of study beyond the data analysis project that involves testing the connectivity links that were identified during the analysis phase.

NHLBI said that the "explosion" of data from genome-wide association studies and functional genomics research have generated large amounts of data that is now made widely available through several major resources, such as the database of Genotypes and Phenotypes, the HuGE Navigator, GWAS Central, GAWS DB, the Gene Expression Omnibus (GEO) repository, and the ArrayExpress Archive. The aim of this program is to put that data to work to understand lung diseases.

Scientists applying for the funds may propose a range of research projects, including, but not limited to, integrative genomics approaches to identify new therapeutic targets for controlling the progression of lung diseases; identifying early-clinical molecular signatures that reflect the effects of cigarette smoking on the lung and risk of COPD; elucidating molecular signatures to define an index of severity in sleep apnea; integrating gene expression data with clinical phenotypes to identify gene targets and pathways for defining idiopathic pulmonary fibrosis; integrating metabolomic and proteomic measures with genomic data to enhance understanding of acute lung injury; and integrating imaging and 'omics data to define factors involved in regional heterogeneity of lung disease.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.